| Range: | 160.19-279.4 | Vol Avg: | 630050 | Last Div: | 0 | Changes: | -1.04 |
| Beta: | 1.22 | Cap: | 18.25B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Tue May 15 2007 | Empoloyees: | 3000 | ||
| CUSIP: | 45784P101 | CIK: | 0001145197 | ISIN: | US45784P1012 | Country: | US |
| CEO: | Dr. James R. Hollingshead Ph.D. | Website: | https://www.insulet.com | ||||
PODD 262.00 Stock Price Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Stock Details
Neutral 0.07
Insulet to Present at Upcoming Investor Conferences
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global le...
businesswire.com·Fri Nov 15 2024
Positive 0.52
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on the...
zacks.com·Tue Nov 12 2024
Neutral 0.00
Insulet CEO on earnings, GLP-1 and election impact
Jim Hollingshead, Insulet CEO, joins 'Closing Bell: Overtime' to discuss the Insulet earni...
youtube.com·Mon Nov 11 2024
Positive 0.54
Buy, Sell, Or Hold Insulet (PODD) Stock?
Insulet stock (NASDAQ: PODD) surged nearly 10% on Friday, November 8, after the company po...
forbes.com·Mon Nov 11 2024
Neutral 0.00
Insulet Corporation (PODD) Q3 2024 Earnings Call Transcript
Insulet Corporation (PODD) Q3 2024 Earnings Call Transcript...
seekingalpha.com·Fri Nov 08 2024
Positive 0.13
Insulet (PODD) Q3 Earnings and Revenues Top Estimates
Insulet (PODD) came out with quarterly earnings of $0.90 per share, beating the Zacks Cons...
zacks.com·Thu Nov 07 2024
Positive 0.20
Insulet Stock Gains From Expansion Strategies, Innovation
PODD continues to drive increased awareness for Omnipod through its direct-to-consumer adv...
zacks.com·Mon Nov 04 2024
Positive 0.20
Omnipod® 5 App for iPhone® Now Fully Available in the United States
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company)...
businesswire.com·Tue Oct 29 2024
Neutral 0.09
National Campaign Launches to Combat Diabetes Stigma Using Comedy
SAN FRANCISCO , Oct. 10, 2024 /PRNewswire/ -- The Spoonful of Laughter campaign is a natio...
prnewswire.com·Thu Oct 10 2024
Neutral 0.07
Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company)...
businesswire.com·Mon Sep 30 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow